Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors.
- DOI
- 10.1016/j.ejmech.2016.08.068
- Published
- 2016 Nov 29
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2016.08.068,
title = {Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors.},
author = {Han J and Henriksen S and Nørsett KG and Sundby E and Hoff BH},
year = {2016},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2016.08.068},
url = {https://doi.org/10.1016/j.ejmech.2016.08.068}
}RIS
TY - JOUR TI - Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors. AU - Han J AU - Henriksen S AU - Nørsett KG AU - Sundby E AU - Hoff BH PY - 2016 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2016.08.068 UR - https://doi.org/10.1016/j.ejmech.2016.08.068 ER -
APA
J, H., S, H., KG, N., E, S., & BH, H. (2016). Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2016.08.068
Source records
- pubmed · retrieved 2026-09-27T01:42:59.513Z